EN
HI
Summary
As of 13 Nov, 2026, Vivo Bio Tech stock price is ₹16.42. During the trading session, the stock has moved between an intraday low of ₹14.65 and an intraday high of ₹16.89. Over the last 52 weeks, Vivo Bio Tech has traded between ₹12.00 and ₹20.94.
The stock has recorded a trading volume of 2,76,724 shares,. Its Average Traded Price (ATP) is ₹16.28, while the Last Traded Quantity at the Last Traded Price (LTQ@LTP) is 300 @ ₹16.42.
Vivo Bio Tech has an upper circuit limit of ₹16.89 and a lower circuit limit of ₹11.27. The total value traded stands at ₹45.05 L, and the delivery percentage for the day is 74.86%.
The stock is currently traded with a market lot size of 1. Vivo Bio Tech also offers a dividend yield of 0%.
Vivo Bio Tech Share Price Chart
Vivo Bio Tech Share Key Metrics
Volume
2.77 L
Market Cap
36.44 CR
LTQ@LTP
300@16.42
ATP
16.28
Var Margin
25.78 %
Circuit Range
11.27-16.89
Delivery %
74.86 %
Value
45.05 L
ASM/GSM
No
Market Lot
1
Vivo Bio Tech Fundamentals
P/E Ratio
0
P/B Ratio
0.34
Div. Yield
0
Sector P/E
41.06
Sector P/B
3.86
Sec. Div. Yield
0.53
Vivo Bio Tech Resistance and Support
Pivot 14.46
Resistance
First Resistance
14.92
Second Resistance
15.75
Third Resistance
16.21
Support
First Support
13.63
Second Support
13.17
Third Support
12.34
Vivo Bio Tech Historical Data
| Day | Open | Close | Change(%) | Day High | Day Low |
|---|---|---|---|---|---|
| Thu Nov 12 2026 | 14.65 | 16.42 | 16.70% | 16.89 | 14.65 |
| Wed Nov 11 2026 | 14.98 | 14.07 | -4.48% | 15.28 | 14 |
| Mon Nov 09 2026 | 14.98 | 14.73 | -0.34% | 14.98 | 14.19 |
Vivo Bio Tech Corporate Actions
| Date | Agenda |
|---|---|
| 2026-11-11 | Quarterly Results |
| 2026-07-13 | Quarterly Results |
| 2026-05-30 | Audited Results & SoA |
| 2026-05-29 | Audited Results & Scheme of Arrangement |
| 2026-02-13 | Quarterly Results |
| 2025-11-14 | Quarterly Results |
| 2025-08-12 | Quarterly Results |
| 2025-05-19 | Audited Results |
| 2025-01-09 | Quarterly Results |
| 2024-11-21 | Employees Stock Option Plan |
| 2024-11-14 | Quarterly Results |
| 2024-08-10 | Quarterly Results |
Vivo Bio Tech News
Vivo Bio Tech Ltd - 511509 - Board Meeting Outcome for Outcome Of The Board Meeting
Vivo Bio Tech reported Q2 FY27 cons. revenue of ₹17.19 crores and net profit of ₹1.10 crores. The revenue grew 31% YoY while net profit saw a 27% YoY increase. Standalone revenue for the quarter was reported at ₹16.98 crores.
Nov 11 2026 19:16:25
Vivo Bio Tech Management
| Name | Position |
|---|---|
| Bhavish Vijayvargiya | Company Secretary & Compliance Officer |
| M Kalyan Ram | Whole Time Director |
Vivo Bio Tech Similar Stocks
Vivo Bio Tech FAQs
The Buying Price of Vivo Bio Tech share is 16.42 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Vivo Bio Tech stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Vivo Bio Tech, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Vivo Bio Tech shares is 0. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Vivo Bio Tech shares is 0.34. Useful to assess the stock's value relative to its book value.
To assess Vivo Bio Tech’s valuation compare Sector P/E, P/B which are 41.06 & 3.86 with sector averages, along with growth rates and financial metrics.
The Market Cap of Vivo Bio Tech is 36.44 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Vivo Bio Tech share price is 20.94 & 12.00. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Vivo Bio Tech belongs to the Healthcare sector.
Open Your Free
Demat Account Now!
AMC for First Year- Auto Square Off Charges
13 Lakh+ Clients
Expert-Backed
Premium Tools
Open Your Free
Demat Account Now!
- AMC For First Year
- Account Opening Fee
- 13 Lakh+ Clients
- Expert-Backed
- Premium Tools
Invest in VIVOBIOT
